Cervical cancer in Ethiopia - predictors of advanced stage and prolonged time to diagnosis.

Introduction: In Ethiopia, most cervical cancer patients present at advanced cancer stages, long time after they experience first symptoms. We investigated possible predictors of long time spans between symptom onset and pathologic diagnosis (patient intervals). We also aimed to seek out predictors for advanced cancer stage diagnosis.

Cervical Cancer in Ethiopia: The Effect of Adherence to Radiotherapy on Survival.

Background: Discontinuation of radiotherapy (RT) for cervical cancer (CC) in sub-Saharan Africa is common because of patient- and health service-related reasons. This analysis describes toxicities and the effect of adherence on survival.

Materials And Methods: A total of 788 patients with CC (2008-2012) who received RT at Addis Ababa University Hospital were included.

Cervical cancer patients presentation and survival in the only oncology referral hospital, Ethiopia: a retrospective cohort study.

Background: Women infected with Human Immune Deficiency Virus (HIV) are assumed to be at higher risk of developing Cervical Cancer (CC). This is due to a rapid progression of pre-invasive to invasive lesions. However, evidences suggest, due to the availability of antiretroviral therapy (ART) and care services; an improved survival and treatment outcome of CC patients (CCPs) with HIV infection is expected.

Cervical cancer in Ethiopia: survival of 1,059 patients who received oncologic therapy.

Background: Almost 500,000 women are newly diagnosed with cervical cancer (CC) every year, the majority from developing countries. There is little information on the survival of these patients. Our primary objective was to evaluate consecutive CC patients presenting over 4 years at the only radiotherapy center in Ethiopia.